Calcium antagonists and the diabetic patient: a response to recent controversies
- 1 November 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (9) , 40-41
- https://doi.org/10.1016/s0002-9149(98)00757-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDMDiabetes Care, 1998
- Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort studyBMJ, 1998
- Calcium-Channel Blockers for Hypertension — Uncertainty ContinuesNew England Journal of Medicine, 1998
- Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular eventsThe Lancet, 1997
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleedingJournal of Human Hypertension, 1997
- Calcium antagonists: Not appropriate as first line antihypertensive agentsAmerican Journal of Hypertension, 1996
- Calcium antagonists: Still appropriate as first line antihypertensive agentsAmerican Journal of Hypertension, 1996
- Calcium Antagonists Should Continue to Be Used for First-Line Treatment of HypertensionArchives of internal medicine (1960), 1995
- Long‐Term Survival and Use of Antihypertensive Medications in Older PersonsJournal of the American Geriatrics Society, 1995
- Nifedipine and MortalityCirculation, 1995